VisCardia Inc.
VisCardia is a medical device developer based in Portland, Oregon, focused on innovative implantable therapies for heart failure. They aim to change the treatment paradigm with their novel, minimally-invasive Synchronized Diaphragmatic StimulationTM therapy, which modulates intrathoracic pressures to improve cardiac function. The company has concluded initial clinical studies in Europe and is engaged in ongoing research, clinical trials, and regulatory approvals to bring their therapy to market.
Industries
Nr. of Employees
small (1-50)
VisCardia Inc.
8770 SW Nimbus Avenue, Beaverton, OR 97008, United States
Patents
Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health
US-12357825-B2
View DetailsHemodynamic performance enhancement through asymptomatic diaphragm stimulation
US-12144993-B2
View DetailsImplantable medical systems, devices and methods for delivering asymptomatic diaphragmatic stimulation
US-11957914-B2
View DetailsImplantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health
US-11925803-B2
View DetailsImplantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health
US-11911616-B2
View DetailsHemodynamic performance enhancement through asymptomatic diaphragm stimulation
US-11684783-B2
View Details
Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health
US-12357825-B2
View DetailsHemodynamic performance enhancement through asymptomatic diaphragm stimulation
US-12144993-B2
View DetailsImplantable medical systems, devices and methods for delivering asymptomatic diaphragmatic stimulation
US-11957914-B2
View DetailsImplantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health
US-11925803-B2
View DetailsImplantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health
US-11911616-B2
View DetailsHemodynamic performance enhancement through asymptomatic diaphragm stimulation
US-11684783-B2
View DetailsProducts
Implantable diaphragmatic stimulation system
A multi-component implantable system that delivers synchronized electrical stimulation to the diaphragm to modulate intrathoracic pressure pulses and augment cardiac hemodynamics for patients with heart failure and reduced ejection fraction.
Implantable diaphragmatic stimulation system
A multi-component implantable system that delivers synchronized electrical stimulation to the diaphragm to modulate intrathoracic pressure pulses and augment cardiac hemodynamics for patients with heart failure and reduced ejection fraction.
Services
Design and execution of preclinical, first-in-human, and multi-center pilot clinical studies with peer-reviewed publications and conference presentations to evaluate safety and performance of the implantable diaphragmatic stimulation therapy.
Design and execution of preclinical, first-in-human, and multi-center pilot clinical studies with peer-reviewed publications and conference presentations to evaluate safety and performance of the implantable diaphragmatic stimulation therapy.
Expertise Areas
- Implantable medical device development
- Clinical trial management and execution (preclinical to first-in-human and pilot studies)
- Cardiac/extra-cardiac device therapy for heart failure
- Minimally invasive surgical implantation (laparoscopic)
Key Technologies
- Synchronized diaphragmatic stimulation
- Implantable pulse generators
- Bipolar lead electrodes (active fixation)
- Wireless telemetry and external programming